Y-Biologics (XKRX:338840) EV-to-Revenue : 33.81 (As of Jun. 20, 2024)

View and export this data going back to 2023. Start your Free Trial

What is Y-Biologics EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Y-Biologics's enterprise value is ₩137,852 Mil. Y-Biologics's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was ₩4,077 Mil. Therefore, Y-Biologics's EV-to-Revenue for today is 33.81.

The historical rank and industry rank for Y-Biologics's EV-to-Revenue or its related term are showing as below:

XKRX:338840' s EV-to-Revenue Range Over the Past 10 Years
Min: 25.65 Med: 30.49 Max: 57.65
Current: 33.8

During the past 6 years, the highest EV-to-Revenue of Y-Biologics was 57.65. The lowest was 25.65. And the median was 30.49.

XKRX:338840's EV-to-Revenue is ranked worse than
73.89% of 1034 companies
in the Biotechnology industry
Industry Median: 7.565 vs XKRX:338840: 33.80

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-06-20), Y-Biologics's stock price is ₩10220.00. Y-Biologics's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ₩312.52. Therefore, Y-Biologics's PS Ratio for today is 32.70.

Y-Biologics EV-to-Revenue Historical Data

The historical data trend for Y-Biologics's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Y-Biologics EV-to-Revenue Chart

Y-Biologics Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

EV-to-Revenue

Get a 7-Day Free Trial

Y-Biologics Quarterly Data
	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EV-to-Revenue	Get a 7-Day Free Trial				-	-	-	56.04	39.79

Competitive Comparison of Y-Biologics's EV-to-Revenue

For the Biotechnology subindustry, Y-Biologics's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Y-Biologics's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Y-Biologics's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Y-Biologics's EV-to-Revenue falls into.

Y-Biologics EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Y-Biologics's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	137852.487	/	4077.165
	=	33.81

Y-Biologics's current Enterprise Value is ₩137,852 Mil.
Y-Biologics's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩4,077 Mil.

Y-Biologics (XKRX:338840) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Y-Biologics's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	10220.00	/	312.516
	=	32.70

Y-Biologics's share price for today is ₩10220.00.
Y-Biologics's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩312.52.

Y-Biologics EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Y-Biologics's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Y-Biologics (XKRX:338840) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Y-Biologics Inc (XKRX:338840) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 715, 17, Tech-ro 4-ro, Yuseong-gu, Daejeon, KOR

Website

https://www.ybiologics.com

Y-Biologics Inc is a company has a variety of development candidate antibodies based on Korea's highest-level antibody discovery platform technology and then independently develops antibody treatments or jointly develops cutting-edge biopharmaceuticals by fusing them with our partner's platform technology. Its main business model is based on a globally competitive antibody discovery platform and consists of development of new bio drug candidates and early technology transfer, and contract research services that generate stable cash flow.

Y-Biologics (XKRX:338840) Headlines

No Headlines